The Valley Desk

ReviewCritical reviews in oncology/hematologyPublished

PD-1/PD-L1 inhibitors in advanced, unresectable esophageal squamous-cell carcinoma: A meta-analysis of their effects across patient subgroups

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Capital Health. Affiliation source

Institution
Capital Health

Publication record

Type
Review
Venue
Critical reviews in oncology/hematology
Published
Subject terms
Humans; Esophageal Neoplasms; Programmed Cell Death 1 Receptor; B7-H1 Antigen; Esophageal Squamous Cell Carcinoma; Immune Checkpoint Inhibitors; ESCC; Esophageal Squamous-cell Carcinoma; Pd-1 Inhibitor; Immune Check Points; Pd-1/pd-l1 Inhibitors
PubMed ID
40769303
Added to directory
Source checked

Report a correction or request removal